Imagion Biosystems is pleased to provide its investors with its March 2021 Investor Newsletter. The newsletter details recent new company developments and activities, including:

• Message from the CEO, Mr Robert Proulx
• Study design at a glance – MagSense^® HER2 breast cancer Phase 1 study
• CSIRO funding received to jump start prostate cancer project
• Prostate Cancer Q&A with Professor Lisa Horvarth, IBX Scientific Advisory Board and Professor Roger Daly, Monash University
• Imagion Biosystems 2020 Annual Report
• How to exercise your options

The investor newsletter can be viewed here. Imagion Biosystems normally distributes this update as an e-newsletter. Investors can sign up to receive email updates at this link: http://ems.gs/3FuT0frcGxD